Attached files

file filename
10-K - 10-K - SPECTRUM PHARMACEUTICALS INCa55483e10vk.htm
EX-21 - EX-21 - SPECTRUM PHARMACEUTICALS INCa55483exv21.htm
EX-31.2 - EX-31.2 - SPECTRUM PHARMACEUTICALS INCa55483exv31w2.htm
EX-32.1 - EX-32.1 - SPECTRUM PHARMACEUTICALS INCa55483exv32w1.htm
EX-23.2 - EX-23.2 - SPECTRUM PHARMACEUTICALS INCa55483exv23w2.htm
EX-31.1 - EX-31.1 - SPECTRUM PHARMACEUTICALS INCa55483exv31w1.htm
EX-32.2 - EX-32.2 - SPECTRUM PHARMACEUTICALS INCa55483exv32w2.htm
EX-10.29 - EX-10.29 - SPECTRUM PHARMACEUTICALS INCa55483exv10w29.htm
EX-10.37 - EX-10.37 - SPECTRUM PHARMACEUTICALS INCa55483exv10w37.htm
EX-10.36 - EX-10.36 - SPECTRUM PHARMACEUTICALS INCa55483exv10w36.htm
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-163366, 333-150260, 333-142628, 333-135029, 333-125208, 333-121612, 333-115759, 333-110103, 333-108658, 333-105814, 333-102587, 333-64444, 333-64432, 333-60966, 333-51388, 333-42852, 333-38710, 333-37180, 333-92855, 333-73009, 333-52331, 333-37585) and Form S-8 (Nos. 333-160312, 333-160705, 333-164014, 333-134566, 333-119833, 333-106427, 333-54246, 333-30345) of Spectrum Pharmaceuticals, Inc. and in the related Prospectuses of our reports dated April 2, 2010, with respect to the 2009 consolidated financial statements of Spectrum Pharmaceuticals, Inc. and the effectiveness of internal control over financial reporting of Spectrum Pharmaceuticals, Inc., as of December 31, 2009, included in this Annual Report (Form 10-K) for the year ended December 31, 2009.
         
     
/s/ Ernst & Young, LLP      
     
Orange County, California
April 2, 2010